Dalton, Greiner, Hartman, Maher & Co’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-520,284
Closed -$11.8M 180
2016
Q3
$11.8M Sell
520,284
-552,153
-51% -$12.1M 0.77% 64
2016
Q2
$20.3M Buy
1,072,437
+478,162
+80% +$9.98M 1.26% 16
2016
Q1
$15.5M Buy
594,275
+83,991
+16% +$1.94M 0.96% 42
2015
Q4
$13.1M Sell
510,284
-190,937
-27% -$5.15M 0.75% 68
2015
Q3
$15.8M Buy
701,221
+229,678
+49% +$5.89M 0.88% 50
2015
Q2
$14.1M Sell
471,543
-198,215
-30% -$5.58M 0.73% 61
2015
Q1
$16.3M Buy
669,758
+177,086
+36% +$3.98M 0.92% 37
2014
Q4
$11M Buy
492,672
+94,508
+24% +$2.24M 0.6% 71
2014
Q3
$10.1M Sell
398,164
-13,406
-3% -$371K 0.57% 70
2014
Q2
$11.3M Buy
+411,570
New +$11.3M 0.6% 74

Other funds holding TBI

Dalton, Greiner, Hartman, Maher & Co's TBI Position: Q4 2016 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Trueblue (TBI) in Q4 2016, closing a stake of 520,284 shares — an estimated $11.8M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in TBI in Q2 2014 and held it in 10 quarters. The position peaked at $20.3M in Q2 2016. 182 funds tracked by Wall St. Rank hold TBI as of Q4 2016.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Trueblue position as of Q4 2016 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 520,284 Trueblue shares in Q4 2016, an estimated $11.8M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Trueblue in Q2 2014 and held it in 10 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Trueblue position peaked at $20.3M in Q2 2016.
  • 182 funds tracked by Wall St. Rank held Trueblue as of Q4 2016.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q4 2016, filed 13 Jan 2017.